Detalhe da pesquisa
1.
Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome.
EFSA J
; 21(2): e07744, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36818642
2.
Guidance on protocol development for EFSA generic scientific assessments.
EFSA J
; 21(10): e08312, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37908452
3.
EFSA's framework for evidence-based scientific assessments: A case study on uncertainty analysis.
ALTEX
; 39(3): 451462, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34185094
4.
Update of environmental risk assessment conclusions and risk management recommendations of EFSA (2016) on EU teosinte.
EFSA J
; 20(4): e07228, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35386925
5.
Application of evidence-based methods to construct mechanism-driven chemical assessment frameworks.
ALTEX
; 39(3): 499518, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35258090
6.
Recommendations for the conduct of systematic reviews in toxicology and environmental health research (COSTER).
Environ Int
; 143: 105926, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653802
7.
Implementing systematic review techniques in chemical risk assessment: Challenges, opportunities and recommendations.
Environ Int
; 92-93: 556-64, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26687863
8.
Using scientific evidence to inform public policy on the long distance transportation of animals: role of the European Food Safety Authority.
Vet Ital
; 44(1): 87-94, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-20405415